KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Resmed (RMD) Amortization - Intangibles (2016 - 2025)

Resmed (RMD) has disclosed Amortization - Intangibles for 17 consecutive years, with $11.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortization - Intangibles rose 6.49% year-over-year to $11.8 million, compared with a TTM value of $50.3 million through Dec 2025, down 2.31%, and an annual FY2025 reading of $45.3 million, down 2.68% over the prior year.
  • Amortization - Intangibles was $11.8 million for Q4 2025 at Resmed, down from $12.0 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $21.8 million in Q2 2021 and bottomed at $695000.0 in Q2 2023.
  • Average Amortization - Intangibles over 5 years is $11.0 million, with a median of $11.0 million recorded in 2021.
  • The sharpest move saw Amortization - Intangibles plummeted 91.21% in 2023, then soared 3000.0% in 2024.
  • Year by year, Amortization - Intangibles stood at $7.7 million in 2021, then fell by 5.6% to $7.3 million in 2022, then skyrocketed by 58.48% to $11.6 million in 2023, then fell by 4.58% to $11.0 million in 2024, then rose by 6.49% to $11.8 million in 2025.
  • Business Quant data shows Amortization - Intangibles for RMD at $11.8 million in Q4 2025, $12.0 million in Q3 2025, and $15.7 million in Q2 2025.